TENX
NASDAQ · Biotechnology
Tenax Therapeutics Inc
$12.73
+0.37 (+2.99%)
Open$12.39
Previous Close$12.36
Day High$13.12
Day Low$12.20
52W High$38.36
52W Low$28.57
Volume—
Avg Volume187.1K
Market Cap79.48M
P/E Ratio16.96
EPS$1.88
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+161.8% upside
Current
$12.73
$12.73
Target
$33.33
$33.33
$30.09
$33.33 avg
$42.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.99M | 20.76M | 15.61M |
| Net Income | 4.98M | 4.98M | 3.68M |
| Profit Margin | 24.9% | 24.0% | 23.6% |
| EBITDA | 7.23M | 8.32M | 5.37M |
| Free Cash Flow | 5.95M | 3.82M | 3.47M |
| Rev Growth | +24.3% | +21.0% | +20.1% |
| Debt/Equity | 0.81 | 0.72 | 0.85 |
Dividend
Dividend Yield1.48%
Annual Dividend$0.47
Payout Ratio25.1%
Frequencyquarterly
Ex-DividendMar 22, 2026
Pay DateApr 8, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |